Skip to main content

and
  1. No Access

    Article

    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

    P. Tappenden, Y. Wang, B. Sharrack, J. Burman, M. Kazmi in Bone Marrow Transplantation (2020)

  2. No Access

    Article

    Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective

    The National Institute for Health and Care Excellence (NICE) invited Gilead, the company manufacturing ledipasvir-sofosbuvir (LDV/SOF), to submit evidence for the clinical effectiveness and cost effectiveness ...

    P. Thokala, E. L. Simpson, P. Tappenden, J. W. Stevens, K. Dickinson in PharmacoEconomics (2016)

  3. No Access

    Article

    Bivalirudin for the Treatment of ST-Segment Elevation Myocardial Infarction: A NICE Single Technology Appraisal

    The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer (The Medicines Company) of bivalirudin to submit evidence for its clinical and cost effectiveness within its licensed i...

    E. L. Simpson, P. Fitzgerald, P. Evans, P. Tappenden, N. Kalita in PharmacoEconomics (2013)

  4. Article

    Open Access

    Reply: cost-effectiveness of population-based screening for colorectal cancer

    L Sharp, C Walsh, S Whyte, L Tilson, A O'Ceilleachair, C Usher in British Journal of Cancer (2013)

  5. No Access

    Article

    Cost of care for colorectal cancer in Ireland: a health care payer perspective

    Management options for colorectal cancer have expanded in recent years. We estimated average lifetime cost of care for colorectal cancer in Ireland in 2008, from the health care payer perspective.

    L. Tilson, L. Sharp, C. Usher, C. Walsh in The European Journal of Health Economics (2012)

  6. Article

    Open Access

    Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy

    Several colorectal cancer-screening tests are available, but it is uncertain which provides the best balance of risks and benefits within a screening programme. We evaluated cost-effectiveness of a population-...

    L Sharp, L Tilson, S Whyte, A O'Ceilleachair, C Walsh, C Usher in British Journal of Cancer (2012)

  7. No Access

    Article

    Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis

    Treatment options for secondary progressive multiple sclerosis (SPMS) are limited. Mitoxantrone is routinely used to stabilize disease progression; however, evolving evidence suggests clinical benefit from int...

    P Tappenden, R Saccardi, C Confavreux, B Sharrack in Bone Marrow Transplantation (2010)

  8. No Access

    Article

    The costs and benefits of bowel cancer service developments using discrete event simulation

    Colorectal cancer includes cancerous growths in the colon, rectum and appendix and affects around 30 000 people in England each year. Maximizing health benefits for patients with colorectal cancer requires con...

    H Pilgrim, P Tappenden, J Chilcott in Journal of the Operational Research Society (2009)

  9. Article

    Open Access

    Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

    For many years, the standard treatment for stage III colon cancer has been surgical resection followed by 5-fluorouracil in combination with folinic acid (5-FU/LV). Ongoing clinical trial evidence suggests tha...

    S Eggington, P Tappenden, A Pandor, S Paisley, M Saunders in British Journal of Cancer (2006)